Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Events symbols : Imux save search
Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024
Published: 2024-02-29 (Crawled : 16:00) - biospace.com/
IMUX | $1.2 -5.51% -5.83% 360K
|
Health Technology
|
| O: 0.71%
H: 4.26%
C: 3.9%
trials
Immunic to Participate in Investor and Scientific Conferences in February
Published: 2024-02-01 (Crawled : 23:00) - biospace.com/
IMUX | $1.2 -5.51% -5.83% 360K
|
Health Technology
|
| O: 1.68%
H: 2.49%
C: 1.65%
Immunic to Participate in Investor and Scientific Conferences in August 2023
Published: 2023-08-01 (Crawled : 12:00) - biospace.com/
IMUX | $1.2 -5.51% -5.83% 360K
|
Health Technology
|
| O: -1.24%
H: 0.63%
C: -2.1%
Immunic to Participate in Investor and Scientific Conferences in May 2023
Published: 2023-04-26 (Crawled : 11:00) - biospace.com/
IMUX | $1.2 -5.51% -5.83% 360K
|
Health Technology
|
| O: 0.0%
H: 5.77%
C: 4.49%
Immunic to Participate in Scientific and Industry Conferences in October 2022
Published: 2022-10-04 (Crawled : 12:00) - biospace.com/
IMUX | $1.2 -5.51% -5.83% 360K
|
Health Technology
|
| O: 1.9%
H: 20.19%
C: 10.87%
Immunic, Inc. to Participate in Scientific, Industry and Investor Conferences in June 2022
Published: 2022-06-08 (Crawled : 12:00) - biospace.com/
IMUX | $1.2 -5.51% -5.83% 360K
|
Health Technology
|
| O: 11.31%
H: 10.7%
C: 6.95%
Immunic, Inc. to Present Preclinical Data for Vidofludimus Calcium at the 17th Congress of European Crohn's and Colitis Organization
Published: 2022-02-18 (Crawled : 12:30) - biospace.com/
IMUX | $1.2 -5.51% -5.83% 360K
|
Health Technology
|
| O: -1.16%
H: 0.47%
C: -1.88%
europe preclinical pre-clinical vidofludimus calcium
Immunic, Inc. to Participate in the Piper Sandler & Co. 33rd Annual Virtual Healthcare Conference
Published: 2021-11-23 (Crawled : 12:30) - biospace.com/
IMUX | $1.2 -5.51% -5.83% 360K
|
Health Technology
|
| O: -5.27%
H: 3.29%
C: 2.84%
conference
Immunic, Inc. to Participate in Scientific and Investor Conferences in October 2021
Published: 2021-09-28 (Crawled : 11:00) - biospace.com/
IMUX | $1.2 -5.51% -5.83% 360K
|
Health Technology
|
| O: 0.0%
H: 0.21%
C: -4.52%
conference
Immunic, Inc. to Participate in Investor and Scientific Conferences in September 2021
Published: 2021-09-08 (Crawled : 12:00) - biospace.com/
IMUX | $1.2 -5.51% -5.83% 360K
|
Health Technology
|
| O: -1.36%
H: 2.8%
C: 1.16%
conference
Immunic, Inc. to Participate in Scientific, Industry and Investor Conferences in July 2021
Published: 2021-06-28 (Crawled : 12:00) - biospace.com/
IMUX | $1.2 -5.51% -5.83% 360K
|
Health Technology
|
| O: -1.16%
H: 3.84%
C: 2.04%
conference
Immunic, Inc. to Participate in Industry and Investor Conferences in June 2021
Published: 2021-06-10 (Crawled : 12:00) - biospace.com/
IMUX | $1.2 -5.51% -5.83% 360K
|
Health Technology
|
| O: -0.28%
H: 3.19%
C: 2.5%
conference
Immunic, Inc. to Participate in Scientific, Investor and Industry Conferences in April 2021
Published: 2021-04-13 (Crawled : 12:00) - biospace.com/
IMUX | $1.2 -5.51% -5.83% 360K
|
Health Technology
|
| O: 0.77%
H: 1.53%
C: -1.32%
conference
Immunic, Inc. to Participate in the SVB Leerink 10th Annual Global Healthcare Conference on February 25
Published: 2021-02-11 (Crawled : 15:00) - biospace.com/
IMUX | $1.2 -5.51% -5.83% 360K
|
Health Technology
|
| O: 4.43%
H: 0.26%
C: -10.53%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.